|
Prednisone/ prednisolone Clinical Trials
6 actively recruiting trials across 5 locations
▲ +2 trials since May 2026
Also known as: Deltasone/Omnipred, Deltasone®/OMNIPRED®, Prednisolone
Pipeline
Phase 2: 1Phase 3: 4Phase 4: 1
Top Sponsors
- Regeneron Pharmaceuticals2
- Celgene1
- BioNTech SE1
- AstraZeneca1
- Alexion Pharmaceuticals, Inc.1
Indications
- Cancer6
- Metastatic Castration-resistant Prostate Cancer2
- gMG1
- Follicular Lymphoma ( FL)1
- Diffuse Large B-cell Lymphoma(DLBCL)1
Los Angeles, California2 trials
Birmingham, Alabama1 trial
Tucson, Arizona1 trial
Chicago, Illinois1 trial
Rockville, Maryland1 trial
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Maryland Oncology Hematology
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.